1Borchers AT, Selmi C, Meyers FJ, et al. Probiotics and immunity. J Gastroenterol, 2009,44:26-46.
2Sutton A. Product development of probiotics as biological drugs. Clin Infect Dis, 2008, 2 : S128-132, S144-151.
3Buts JP, Bernasconi P. Saccharomyces boulardii: basic science and clinical applications in gastroenterology. Gastroenterol Clin North Am, 2005,34:515-532.
4Buts JP, De Keyser N. Transduction pathways regulating the trophic effects of Saecharomyces boulardii in rat intestinal rnucosa. Seand J Gastroenterol, 2010,45 : 175-185.
5Buts JP, De Keyser N. Effects of Saecharornyces boulardii on intestinal mueosa. Dig Dis Sci, 2006,51 : 1485-1492.
6Costalos C,Skouteri V, Gounaris A, et al. Enteral feeding of premature infants with Saccharomyees boulardii. Early Hum Dev, 2003 74.89-96.
7Agarwal HK. Frobiotics--the health lriendly gut bacteria. Indian Pediatr, 2008,45:953-954.
8Mohan R, Koebnick C, Schildt J, et al. Effects of Bifidobaetefium lacfis Bbl2 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatr Res, 2008,64:418-422.
9Fujii T, Ohtsuka Y, Lee T, et al. Bifidobacterium breve enhances transforming growth factor beta1 signaling by regulating Smad7 expression in preterm infants. J Pediatr Gastroenterol Nutr, 2006,43:83-88.
10Alfaleh K, Anabrees J, Bassler D, et al. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Obstet Gynecol, 2008,111:1202-1204.
